secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001437749-25-030813
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics raises CEO and COO salaries, sets Dec 16 annual meeting
------------------------------------------------------------------------

- CEO David E. Jorden salary increased to $325,000 effective Oct 1, 2025.
- COO Peter A. Clausen salary increased to $290,000 effective same date.
- Annual meeting scheduled for Dec 16, 2025 at Houston principal executive office.
- Shareholder proposals and director nominations deadline is Oct 20, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774925030813/0001437749-25-030813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774925030813/aurx20251009_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-030813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer